Skip to main content
Erschienen in: Surgery Today 4/2016

01.04.2016 | Original Article

Impact of inappropriate lymphadenectomy on lung metastasectomy for patients with metastatic colorectal cancer

verfasst von: Sergi Call, Ramón Rami-Porta, Raúl Embún, Laura Casas, Juan J. Rivas, Laureano Molins, José Belda-Sanchís

Erschienen in: Surgery Today | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the characteristics of lymph node assessment in the Spanish Colorectal Metastasectomy Registry (GECMP-CCR) and to analyze and compare the survival of patients with pathological absence or presence of lymph node metastases (LNM) with the survival of those with uncertain lymph node status (uLNs).

Methods

A total of 522 patients with lung metastases from colorectal carcinoma were prospectively registered from 2008 to 2010. To confirm the pathologic absence of LNM, systematic nodal dissection or systematic sampling was required, or the lymph node status was coded as uncertain. Disease-specific survival and disease-free survival were calculated by the Kaplan–Meier method with the log-rank test for comparisons.

Results

Lymphadenectomy was performed in 250 (48 %) patients. LNM was found in 25 (10 %) of the patients who had lymph node assessment done. The 3- and 5-year disease-specific survival rates according to lymph node status were 73.5 and 58.3 % in the absence of LNM, 50.5 and 24.8 % when LNM was confirmed, and 69 and 44 % for those with uLNs, respectively (p = 0.006).

Conclusions

The presence of LNM and uLNs is associated with an increased risk of death. The association of nodal assessment at the time of metastasectomy to identify LNM helps us to refine the postoperative prognosis; therefore, its impact should be properly studied in a prospective clinical trial.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pastorino U, Buyse M, Friedel G. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg. 1997;113:37–49.CrossRefPubMed Pastorino U, Buyse M, Friedel G. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg. 1997;113:37–49.CrossRefPubMed
2.
Zurück zum Zitat Dominguez-Ventura A, Nichols FC. Lymphadenectomy in metastasectomy. Thorac Surg Clin. 2006;16:139–43.CrossRefPubMed Dominguez-Ventura A, Nichols FC. Lymphadenectomy in metastasectomy. Thorac Surg Clin. 2006;16:139–43.CrossRefPubMed
3.
Zurück zum Zitat Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2012;20:572–9.CrossRefPubMed Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2012;20:572–9.CrossRefPubMed
4.
Zurück zum Zitat Embun R, Fiorentino F, Treasure T, Rivas JJ, Molins L. Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR). BMJ Open. 2013;3(5):e002787. doi:10.1136/bmjopen-2013-002787.PubMedCentralCrossRefPubMed Embun R, Fiorentino F, Treasure T, Rivas JJ, Molins L. Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR). BMJ Open. 2013;3(5):e002787. doi:10.​1136/​bmjopen-2013-002787.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica GCCB-S. Estadificación ganglionar intraoperatoria en la cirugía del carcinoma broncogénico. Documento de consenso. Arch Bronconeumol. 2001;37:495–503.CrossRef Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica GCCB-S. Estadificación ganglionar intraoperatoria en la cirugía del carcinoma broncogénico. Documento de consenso. Arch Bronconeumol. 2001;37:495–503.CrossRef
6.
Zurück zum Zitat Martini N, McCormack PM. Evolution of the surgical management of pulmonary metastases. Chest Surg Clin N Am. 1998;8:13–27.PubMed Martini N, McCormack PM. Evolution of the surgical management of pulmonary metastases. Chest Surg Clin N Am. 1998;8:13–27.PubMed
7.
Zurück zum Zitat Treasure T, Milosevic M, Fiorentino F, Macbeth F. Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness? Thorax. 2014;69:946–9.PubMedCentralCrossRefPubMed Treasure T, Milosevic M, Fiorentino F, Macbeth F. Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness? Thorax. 2014;69:946–9.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Rami-Porta R, Wittekind C, Goldstraw P; International Association for the lung cancer (IASLC) Staging Comitee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 2005;49:25–33.CrossRef Rami-Porta R, Wittekind C, Goldstraw P; International Association for the lung cancer (IASLC) Staging Comitee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 2005;49:25–33.CrossRef
9.
Zurück zum Zitat Internullo E, Cassivi SD, Van Raemdonck D, Friedel G, Treasure T. Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thorac Oncol. 2008;3:1257–66.CrossRefPubMed Internullo E, Cassivi SD, Van Raemdonck D, Friedel G, Treasure T. Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thorac Oncol. 2008;3:1257–66.CrossRefPubMed
10.
Zurück zum Zitat Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg. 2006;81:448–54.CrossRefPubMed Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg. 2006;81:448–54.CrossRefPubMed
11.
Zurück zum Zitat Renaud S, Alifano M, Falcoz PE, Magdeleinat P, Santelmo N, Pagès O, et al. Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer. Interact CardioVasc Thorac Surg. 2014;18:482–7.PubMedCentralCrossRefPubMed Renaud S, Alifano M, Falcoz PE, Magdeleinat P, Santelmo N, Pagès O, et al. Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer. Interact CardioVasc Thorac Surg. 2014;18:482–7.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol. 2010;5(6 Suppl 2):S172–8.CrossRefPubMed Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol. 2010;5(6 Suppl 2):S172–8.CrossRefPubMed
13.
Zurück zum Zitat Hirosawa T, Itabashi M, Ohnuki T, Yamaguchi N, Sugihara K, Kameoka S, et al. Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: amulti-institutional cumulative follow-up study. Surg Today. 2013;43:494–9.CrossRefPubMed Hirosawa T, Itabashi M, Ohnuki T, Yamaguchi N, Sugihara K, Kameoka S, et al. Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: amulti-institutional cumulative follow-up study. Surg Today. 2013;43:494–9.CrossRefPubMed
14.
Zurück zum Zitat Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, et al. Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer. Surg Today. 2015;45:315–21.CrossRefPubMed Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, et al. Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer. Surg Today. 2015;45:315–21.CrossRefPubMed
15.
Zurück zum Zitat Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg. 2007;31:167–72.CrossRefPubMed Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg. 2007;31:167–72.CrossRefPubMed
16.
Zurück zum Zitat Hamaji M, Cassivi SD, Shen KR, Shen R, Allen M, Nichols FC, et al. Is lymph node dissection required in pulmonary metastasectomy for colorectal adenocarcinoma? Ann Thorac Surg. 2012;94:1796–800.CrossRefPubMed Hamaji M, Cassivi SD, Shen KR, Shen R, Allen M, Nichols FC, et al. Is lymph node dissection required in pulmonary metastasectomy for colorectal adenocarcinoma? Ann Thorac Surg. 2012;94:1796–800.CrossRefPubMed
17.
Zurück zum Zitat Garcia-Yuste M, Cassivi S, Paleru C. Thoracic lymphatic involvement in patients having pulmonary metastasectomy: incidence and the effect on prognosis. J Thorac Oncol. 2010;5(6 Suppl 2):S166–9.CrossRefPubMed Garcia-Yuste M, Cassivi S, Paleru C. Thoracic lymphatic involvement in patients having pulmonary metastasectomy: incidence and the effect on prognosis. J Thorac Oncol. 2010;5(6 Suppl 2):S166–9.CrossRefPubMed
18.
Zurück zum Zitat Osarogiagbon RU, Yu X. Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer. Ann Thorac Surg. 2013;96:1178–89.CrossRefPubMed Osarogiagbon RU, Yu X. Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer. Ann Thorac Surg. 2013;96:1178–89.CrossRefPubMed
19.
Zurück zum Zitat Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE 2nd, Landreneau RJ, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81:1013–9.CrossRefPubMed Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE 2nd, Landreneau RJ, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81:1013–9.CrossRefPubMed
20.
Zurück zum Zitat Maniwa T, Okumura T, Isaka M, Nakagawa K, Ohde Y, Kondo H. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;44:e59–64.CrossRefPubMed Maniwa T, Okumura T, Isaka M, Nakagawa K, Ohde Y, Kondo H. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;44:e59–64.CrossRefPubMed
21.
Zurück zum Zitat Kamiyoshihara M, Hirai T, Kawashima O, Ishikawa S, Morishita Y. The surgical treatment of metastatic tumors in the lung: is lobectomy with mediastinal lymph node dissection suitable treatment? Oncol Rep. 1998;5:453–7.PubMed Kamiyoshihara M, Hirai T, Kawashima O, Ishikawa S, Morishita Y. The surgical treatment of metastatic tumors in the lung: is lobectomy with mediastinal lymph node dissection suitable treatment? Oncol Rep. 1998;5:453–7.PubMed
22.
Zurück zum Zitat Okumura S, Kondo H, Tsuboi M, Nakayama H, Asamura H, Tsuchiya R, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg. 1996;112:867–74.CrossRefPubMed Okumura S, Kondo H, Tsuboi M, Nakayama H, Asamura H, Tsuchiya R, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg. 1996;112:867–74.CrossRefPubMed
23.
Zurück zum Zitat Treasure T, Fallowfield L, Lees B, Farewell V. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. Thorax. 2012;67:185–7.CrossRefPubMed Treasure T, Fallowfield L, Lees B, Farewell V. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. Thorax. 2012;67:185–7.CrossRefPubMed
Metadaten
Titel
Impact of inappropriate lymphadenectomy on lung metastasectomy for patients with metastatic colorectal cancer
verfasst von
Sergi Call
Ramón Rami-Porta
Raúl Embún
Laura Casas
Juan J. Rivas
Laureano Molins
José Belda-Sanchís
Publikationsdatum
01.04.2016
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 4/2016
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-015-1214-3

Weitere Artikel der Ausgabe 4/2016

Surgery Today 4/2016 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.